Rivastigmine From Capsules to Patch: Therapeutic Advances in the Management of Alzheimer’s Disease and Parkinson’s Disease Dementia

di Sadowsky, Carl H., Micca, Joseph L., Grossberg, George T., Velting, Drew M.
Pubblicato in Prim Care Companion CNS Disord (2014)

A practical algorithm for managing Alzheimer's disease: what, when, and why?

di Cummings, Jeffrey L, Isaacson, Richard S, Schmitt, Frederick A, Velting, Drew M
Pubblicato in Ann Clin Transl Neurol (2015)

Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer’s disease

di Micca, Joseph L, Galvin, James E, Velting, Drew M, Meng, Xiangyi
Pubblicato in SAGE Open Med (2014)

Evaluating Response to High‐Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease

di Farlow, Martin R., Sadowsky, Carl H., Velting, Drew M., Meng, Xiangyi, Islam, M. Zahur
Pubblicato in CNS Neurosci Ther (2015)